Stockreport

Xencor: Plamotamab NHL Data Leads To RA Program Advancement [Seeking Alpha]

Xencor, Inc.  (XNCR) 
Last xencor, inc. earnings: 2/24 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.xencor.com/investor-relations
PDF Terry Chrisomalis Investing Group Leader Follow Play 15min Summary Xencor's Phase 1 data using Plamotamab for the treatment of relapsed/refractory Non-Hodgk [Read more]